Ortivus has secured a 10 MSEK credit line agreement with its principal owner
Prenumeration
Kalender
| Tid* | ||
| 2025-05-08 | N/A | Årsstämma |
| 2025-05-08 | 08:30 | Kvartalsrapport 2025-Q1 |
| 2025-02-14 | 08:30 | Bokslutskommuniké 2024 |
| 2024-11-08 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-23 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-10 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
| 2024-05-10 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
| 2024-05-08 | - | Årsstämma |
| 2024-05-08 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-16 | - | Bokslutskommuniké 2023 |
| 2023-11-10 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-25 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-05 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
| 2023-05-05 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
| 2023-05-04 | - | Årsstämma |
| 2023-05-04 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-17 | - | Bokslutskommuniké 2022 |
| 2022-11-11 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-25 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-06 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
| 2022-05-06 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
| 2022-05-05 | - | Årsstämma |
| 2022-04-27 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-16 | - | Bokslutskommuniké 2021 |
| 2021-11-12 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-20 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-06 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
| 2021-05-06 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
| 2021-05-05 | - | Årsstämma |
| 2021-04-27 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-16 | - | Bokslutskommuniké 2020 |
| 2020-11-10 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-21 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-13 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
| 2020-05-13 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
| 2020-05-04 | - | Årsstämma |
| 2020-04-23 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-18 | - | Årsstämma |
| 2020-02-13 | - | Årsstämma |
| 2020-02-13 | - | Bokslutskommuniké 2019 |
| 2019-10-25 | - | Årsstämma |
| 2019-08-22 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-07 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
| 2019-05-07 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
| 2019-05-06 | - | Årsstämma |
| 2019-05-03 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-18 | - | Extra Bolagsstämma 2019 |
| 2019-02-13 | - | Bokslutskommuniké 2018 |
| 2018-11-20 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-24 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-04 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
| 2018-05-04 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
| 2018-05-03 | - | Årsstämma |
| 2018-04-30 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-08 | - | Bokslutskommuniké 2017 |
| 2017-11-21 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-22 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-12 | - | Extra Bolagsstämma 2017 |
| 2017-05-02 | - | Kvartalsrapport 2017-Q1 |
| 2017-05-02 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
| 2017-05-02 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
| 2017-04-28 | - | Årsstämma |
| 2017-02-10 | - | Bokslutskommuniké 2016 |
| 2016-10-24 | - | Kvartalsrapport 2016-Q3 |
| 2016-07-13 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-09 | - | Årsstämma |
| 2016-05-02 | - | Kvartalsrapport 2016-Q1 |
| 2016-04-30 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
| 2016-04-30 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
| 2016-02-10 | - | Bokslutskommuniké 2015 |
| 2015-10-20 | - | Kvartalsrapport 2015-Q3 |
| 2015-07-13 | - | Kvartalsrapport 2015-Q2 |
| 2015-04-30 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
| 2015-04-30 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
| 2015-04-29 | - | Årsstämma |
| 2015-04-29 | - | Kvartalsrapport 2015-Q1 |
| 2015-02-17 | - | Bokslutskommuniké 2014 |
| 2014-10-27 | - | Kvartalsrapport 2014-Q3 |
| 2014-07-11 | - | Kvartalsrapport 2014-Q2 |
| 2014-04-30 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
| 2014-04-30 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
| 2014-04-29 | - | Årsstämma |
| 2014-04-29 | - | Kvartalsrapport 2014-Q1 |
| 2014-02-07 | - | Bokslutskommuniké 2013 |
| 2013-10-18 | - | Kvartalsrapport 2013-Q3 |
| 2013-07-12 | - | Kvartalsrapport 2013-Q2 |
| 2013-04-30 | - | Kvartalsrapport 2013-Q1 |
| 2013-04-22 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
| 2013-04-22 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
| 2013-04-19 | - | Årsstämma |
| 2013-02-08 | - | Bokslutskommuniké 2012 |
| 2012-10-18 | - | Kvartalsrapport 2012-Q3 |
| 2012-07-12 | - | Kvartalsrapport 2012-Q2 |
| 2012-05-04 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
| 2012-05-04 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
| 2012-05-03 | - | Årsstämma |
| 2012-04-20 | - | Kvartalsrapport 2012-Q1 |
| 2012-02-22 | - | Bokslutskommuniké 2011 |
| 2011-10-14 | - | Kvartalsrapport 2011-Q3 |
| 2011-08-12 | - | Kvartalsrapport 2011-Q2 |
| 2011-05-31 | - | Extra Bolagsstämma 2010 |
| 2011-05-05 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
| 2011-05-05 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
| 2011-05-04 | - | Årsstämma |
| 2011-04-15 | - | Kvartalsrapport 2011-Q1 |
| 2011-02-18 | - | Bokslutskommuniké 2010 |
| 2010-10-14 | - | Kvartalsrapport 2010-Q3 |
| 2010-08-12 | - | Kvartalsrapport 2010-Q2 |
| 2010-05-04 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
| 2010-05-04 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
| 2010-05-03 | - | Årsstämma |
| 2010-04-22 | - | Kvartalsrapport 2010-Q1 |
| 2010-02-19 | - | Bokslutskommuniké 2009 |
| 2009-11-12 | - | Kvartalsrapport 2009-Q3 |
| 2009-08-14 | - | Kvartalsrapport 2009-Q2 |
| 2009-05-07 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
| 2009-05-07 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
| 2009-05-06 | - | Årsstämma |
| 2009-05-06 | - | Kvartalsrapport 2009-Q1 |
| 1998-04-23 | - | Split ORTI A 1:2 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Small Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
To strengthen its liquidity position, Ortivus has entered into a credit line agreement with its principal owner, Ponderus Invest AB.
The credit line agreement totals 10 MSEK, comprising 5 MSEK in previously provided bridging loans and an additional 5 MSEK in new credit space. Loans under this agreement have a fixed annual interest rate of 8%. Both the credit line and outstanding loans are due for repayment on August 30, 2024, with the option for the company to extend the loan period until December 30, 2024.
The credit line agreement aims to strengthen Ortivus' liquidity, which was negatively impacted by the criminal cyber-attack in July 2023. Additionally, the agreement is intended to cover costs for short-term ongoing deliveries.
As previously communicated, the cyberattack targeted one of Ortivus' subcontractors and affected some of the company's customers in the UK. A legal process is underway to recover lost revenue and accrued costs.
Contacts
For further information, please contact
Gustaf Nordenhök, CEO
Telefon +46 8 446 45 00
About Ortivus
Ortivus develops and commercialises MobiMed, e-health and medical technology solutions for a safer and more efficient healthcare. The company was founded in 1985 and is today a leading provider of mobile digital solutions for prehospital care, worldwide. Ortivus' innovations are based on in-depth expertise in cardiology as well as decades of development together with users and customers. The company's headquarters are located in Danderyd, Stockholm. The company has, since 1998, a wholly owned subsidiary based in the United Kingdom and since 2022, a wholly owned subsidiary based in Denmark.
MobiMed is a modular platform that connects and enable real-time information sharing throughout the prehospital care chain. It is currently used by over 12,000 paramedics in over 2,700 emergency vehicles. The platform, MobiMed, consists of several product modules that are completely integrated but can also be used stand-alone. MobiMed comprises four main solutions: MobiMed Monitor, that measures, monitors and shares patients' vital parameters and ECG in real-time, MobiMed ePR, - an electronic patient record for decision support, collection of patient data and clinical documentation, MobiMed enRoute, - a tool for navigation and case management, and MobiMed Life - a range of stand-alone defibrillators.
MobiMed saves vital seconds and enable healthcare professionals make the right decisions in critical situations. MobiMed also contributes to improved quality of care and saved resources.
Ortivus Class A and Class B shares are listed on the NASDAQ Stockholm Small Cap list.
Read more about Ortivus at www.ortivus.com
This information is information that Ortivus is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2024-06-05 19:00 CEST.